Clinical Trial Update: A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours

View source ↗

Summary

A pharmacodynamic and pharmacogenetic study of OPB-51602 in patients with advanced solid tumors; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• OPB-51602 (OPB-51602)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Advanced Solid Tumors | Status: UNKNOWN